SZ
StageZero Life Sciences Ltd.
SZLSF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $630.0K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.17x
P/E N/A
EV/FFO N/A
Growth
100 /100
Growing Rev. growth 201.33%
EPS growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Gross margin 10.64%
FCF margin 92.98%
Net margin 300.79%
Quality
79 /100
Excellent ROIC 151.85%
Asset turnover 5.42x
ROA 1,629.25%
Debt
50 /100
Moderate Current ratio 0.04x
Net debt/EBITDA -0.17x
Int. coverage -37.63x
Stability
35 /100
Moderate Beta 0.34x
Profitable years 0
Rev. volatility 1,671.49%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SZLSF
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
James R. Howard-Tripp
Employees
40
Headquarters
Richmond Hill
Upcoming events
18 NOV
Earnings
Upcoming earnings report